The Buddhist Compassion Relief Tzu Chi Foundation’s application to import 5 million doses of the BioNTech COVID-19 vaccine will not be considered alongside similar requests tendered by the Yonglin Foundation and Taiwan Semiconductor Manufacturing Co (TSMC) due to differences in their applications, Executive Yuan spokesperson Lo Ping-cheng (羅秉成) said yesterday.
The Tzu Chi Foundation on Wednesday submitted an application to the Food and Drug Administration (FDA), after the Executive Yuan on Friday last week authorized the YongLin Foundation and TSMC to represent the government to purchase vaccines from BioNTech.
After evaluations, the proposals by TSMC and the YongLin Foundation are more feasible and have a greater “chance” of success, Lo told a news conference at the Executive Yuan in Taipei.
Photo courtesy of the Buddhist Compassion Relief Tzu Chi Foundation
The Tzu Chi Foundation’s application is not being merged with the other two due to differences with each application, he said, without elaborating.
International purchases of vaccines are complicated and it is vital to develop a model that has a greater chance of success, Lo said.
None of the applications included an “authorization notice” from the original manufacturer, BioNTech.
It is rare that the first tender of an application includes a manufacturer’s authorization, FDA Director-General Wu Shou-mei (吳秀梅) said on Wednesday, adding that it would look into the Tzu Chi Foundation’s application and ask it to provide any missing documents.
The Tzu Chi Foundation has said that it cannot obtain the manufacturer’s authorization unless the government first approves its application.
Tzu Chi Foundation executive director Yen Po-wen (顏博文) said that it has followed the government regulations and would do its best to provide whatever documents are required.
Should a purchase proceed, vaccines would be directly imported to Taiwan from Germany, Yen said.
Yen denied a rumor that the Tzu Chi Foundation canceled a news conference to announce its vaccine purchase plan after on Monday receiving a call from the Presidential Office.
Chinese Nationalist Party (KMT) Legislator Wen Yu-hsia (溫玉霞) on Monday made the allegation, although the Presidential Office has denied exerting pressure on the Tzu Chi Foundation.
The Tzu Chi Foundation said that it has three reasons for purchasing BioNTech vaccines.
First, it believes that it is the most effective vaccine against COVID-19; second, the manufacturer can supply sufficient doses in an emergency situation; and third, it is the only vaccine on the market that can be administered to 12 to 17-year-olds.
Vaccine import regulations say that applicants must do so through a pharmaceutical company and application must include eight pieces of documentation: plans and methods of execution; a pharmaceutical insert; the amount imported and why the amount was requested; proof of transport and storage at adequate temperatures; the date of vaccine provision; authorization from the original manufacturer; vaccine expiry dates; and proof of pre-market clearance in foreign countries, the Central Epidemic Command Center said last month.
Additional reporting by Wu Liang-yi
‘DENIAL DEFENSE’: The US would increase its military presence with uncrewed ships, and submarines, while boosting defense in the Indo-Pacific, a Pete Hegseth memo said The US is reorienting its military strategy to focus primarily on deterring a potential Chinese invasion of Taiwan, a memo signed by US Secretary of Defense Pete Hegseth showed. The memo also called on Taiwan to increase its defense spending. The document, known as the “Interim National Defense Strategic Guidance,” was distributed this month and detailed the national defense plans of US President Donald Trump’s administration, an article in the Washington Post said on Saturday. It outlines how the US can prepare for a potential war with China and defend itself from threats in the “near abroad,” including Greenland and the Panama
The High Prosecutors’ Office yesterday withdrew an appeal against the acquittal of a former bank manager 22 years after his death, marking Taiwan’s first instance of prosecutors rendering posthumous justice to a wrongfully convicted defendant. Chu Ching-en (諸慶恩) — formerly a manager at the Taipei branch of BNP Paribas — was in 1999 accused by Weng Mao-chung (翁茂鍾), then-president of Chia Her Industrial Co, of forging a request for a fixed deposit of US$10 million by I-Hwa Industrial Co, a subsidiary of Chia Her, which was used as collateral. Chu was ruled not guilty in the first trial, but was found guilty
A wild live dugong was found in Taiwan for the first time in 88 years, after it was accidentally caught by a fisher’s net on Tuesday in Yilan County’s Fenniaolin (粉鳥林). This is the first sighting of the species in Taiwan since 1937, having already been considered “extinct” in the country and considered as “vulnerable” by the International Union for Conservation of Nature. A fisher surnamed Chen (陳) went to Fenniaolin to collect the fish in his netting, but instead caught a 3m long, 500kg dugong. The fisher released the animal back into the wild, not realizing it was an endangered species at
DEADLOCK: As the commission is unable to forum a quorum to review license renewal applications, the channel operators are not at fault and can air past their license date The National Communications Commission (NCC) yesterday said that the Public Television Service (PTS) and 36 other television and radio broadcasters could continue airing, despite the commission’s inability to meet a quorum to review their license renewal applications. The licenses of PTS and the other channels are set to expire between this month and June. The National Communications Commission Organization Act (國家通訊傳播委員會組織法) stipulates that the commission must meet the mandated quorum of four to hold a valid meeting. The seven-member commission currently has only three commissioners. “We have informed the channel operators of the progress we have made in reviewing their license renewal applications, and
RSS